From: Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs
Experimental group (cases)
Control group (cases)
p value
Chemotherapy response
CR
2
1
<0.05
PR
11
5
SD
10
Surgical margin
Negative
13
6
<0.01
Positive
Progression free survival
Yes
4
No
12